Ketamine in Acute Brain Injury Patients.

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Brain Injuries, Traumatic

In brief

Although, in the past years, an increasing use of ketamine in Traumatic Brain injury (TBI) has been reported as an adjunct to other sedatives, there is no evidence from randomized clinical trial to support this practice. The BIKe (Brain Injury and Ketamine) study is a double-blind placebo controlled randomized multicenter clinical trial to examine the safety and feasibility of using ketamine as an adjunct to a standard sedative strategy in TBI patients.

Key facts

Study ID
NCT05097261
Run by
Geert Meyfroidt, MD, PhD
People needed
100
Starts
2021-09-06
Expected to finish
2026-06-30
Last updated by the study team
2024-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.